ICARES Medicus, Inc. (TPEX:6612)

Market Cap	3.34B -35.2%
Revenue (ttm)	1.13B +31.5%
Net Income	51.23M -50.3%
EPS	1.08 -50.5%
Shares Out	47.52M
PE Ratio	65.00
Forward PE	n/a
Dividend	0.30 (0.43%)
Ex-Dividend Date	Aug 22, 2025

Volume	10,191
Average Volume	29,472
Open	69.10
Previous Close	69.10
Day's Range	69.00 - 71.10
52-Week Range	66.00 - 118.64
Beta	0.37
RSI	47.21
Earnings Date	Mar 26, 2026

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, United Kingdom, Japan, Spain, China, Germany, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, farsightedness, presbyopia, or astigmatism, as well as related technical services. In addition, it offers artificial crystal products; and l...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6612

Financial Performance

In 2025, ICARES Medicus's revenue was 1.13 billion, an increase of 31.54% compared to the previous year's 859.79 million. Earnings were 51.23 million, a decrease of -50.32%.